key: cord-0704792-r7nxnhrl authors: Muthuramalingam, Pandiyan; Jeyasri, Rajendran; Valliammai, Alaguvel; Selvaraj, Anthonymuthu; Karthika, Chandrasekar; Gowrishankar, Shanmugaraj; Pandian, Shunmugiah Karutha; Ramesh, Manikandan; Chen, Jen-Tsung title: Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach date: 2020-08-07 journal: Genomics DOI: 10.1016/j.ygeno.2020.08.003 sha: 2bdbadc98448259aa137cdddd453b90fbddd5ed5 doc_id: 704792 cord_uid: r7nxnhrl Abstract Understanding the immunological behavior of COVID-19 cases at molecular level is essential for therapeutic development. In this study, multi-omics and systems pharmacology analyses were performed to unravel the multi-targeted mechanisms of novel bioactives to combat COVID-19. Immuno-transcriptomic dataset of healthy controls and COVID-19 cases was retrieved from ArrayExpress. Phytocompounds from ethnobotanical plants were collected from PubChem. Differentially expressed 98 immune genes associated with COVID-19 were derived through NetworkAnalyst 3.0. Among 259 plant derived compounds, 154 compounds were targeting 13 COVID-19 immune genes involved in diverse signaling pathways. In addition, pharmacological properties of these phytocompounds were compared with COVID-19 drugs prescribed by WHO, and 25 novel phytocompounds were found to be more efficient with higher bioactive scores. The current study unravels the virogenomic signatures which can serve as therapeutic targets and identified phytocompounds with anti-COVID-19 efficacy. However, further experimental validation is essential to bring out these molecules as commercial drug candidates. 122 cases from human transcriptome 123 The human immuno-transcriptomic dataset of healthy controls and COVID-19 cases 124 (E-MTAP-8871) was collected/ retrieved from ArrayExpress database 125 (www.ebi.ac.uk/arrayexpress/). The retrieved dataset was manually curated using MS Excel. 126 Further, this human immuno-transcriptomic data was imported into the Gene Expression In addition to that, the imputation of the bioactive score for the vital targets such as Kinase 171 inhibitor activity (Ki), GPCR ligand activity (GPCR), protease inhibitor activity (Pi), number 172 of violations (nvio), enzymes and nuclear receptors (Ncr) was predicted. Forty-two human COVID-19 receptors and essential immunity genes were collected 188 from the literature [29] . The list of these genes and their functions were given in Table S1 . 189 Protein-protein interactions (PPI) analysis of these COVID-19 receptors, essential immunity The immuno-transcriptomic dataset contains 579 immune responsive genes of which 197 549 genes were commonly found in meta-differential (up, down and non-significant) 198 expression ( Fig. 1) edges and 80 seed proteins ( Fig. 3 and Table S2 ) and the pathway based ORA enrichment 203 network showed the involvement in various biological pathways ( Fig. 4 and Table S3 ). A 259 number of phytochemicals were employed as a query in PubChem database to 206 fetch and retrieve the canonical SMILES (Table S4 ). This obtained SMILES information was 207 used for further biomolecular analyses. Table S5 . orthologs details were retrieved and given in Table 2 . These immune responsive genes with 221 their attributes will pave the way to delineate their detailed molecular function. peptide receptor activity (Fig. 6) . properties of natural bioactive compounds and 25 potential compounds were found to be 261 more efficacious than the WHO prescribed drugs and are listed in Table 4 . infections and the COVID-19 is highly significant at the molecular level. induce the production of anti-COVID-19 antibodies via antigen presenting cells (Fig. 10) . 356 Since synthetic drugs are incapable of producing a breakthrough to date in the treatment of α-humulene α-HM 49. Linolenic acid LLA 50. α-thujene α-TJ 51. β-caryophyllene β-CP 52. β-gurjunene β-GJ 53. β-Pinene β-PN 54. ß-carotene β-CT 55. β-guaiene β-GE 56. β-bisabolene β-BB 57. ß-sitosterol β-SS 58. (E)-beta-ocimene (E)-β-OM 59. 3-Furaldehyde 3-FA Andrographidine A AGA 12. Andrographidine C AGC 13. Luteolin LT 14. 14-Deoxyandrographolide 14-DOA 15. 14-Deoxy 11, 12-didehydroandrographolide 14-D-11,12-DAG J o u r n a l P r e -p r o o f 16. 14-Deoxy-11-hydroxyandrographolide 14-D-11-HAG 17. 14-Deoxy-12-hydroxyandrographolide 14-D-12-HAG 18. 3 -O-beta-D-glucopyranosyl 14, 19dideoxyandrographolide 3-O β-D-G14,19-DDAG 19. 8, 17-Epoxy-14-deoxyandrographolide 8,17-E-14-DAG 20. 3,4-Dicaffeoylquinic acid 3,4-DA Alpinia officinarum S. Pinobaksin PB 20. 5-hydroxy-1,7-diphenyl-3-heptanone -3,5-dihydroxy-1,7-diphenylheptane 5-H-1,7-D-3-H 21. 1,7-diphenylhept-4-en-3-one 1,7-DP-4-E3O 22. Zingerone ZG 23. 1'-acetoxychavicol acetate 1'-ACA 24. β-sitosterol β-SS 25. p-Coumaryl alcohol p-CA 26. 1,5-bis-(4-hydroxyphenyl)-2-(methoxymethyl)-4-pen ten-1-ol β-Caryophyllene β-CP 7. p-Cymene p-CM 8. Caryophyllene oxide CPO 9. α-Terpinene α-TP 10. Spathulenol STL 11. Ethyl Salicylate ES 12. Terpinen-4-ol TP-4-ol 13. α-Terpinolene α-TPL 14. Squalene SQL 15. Oleic acid OA 16. Phytol PT 17. β-Cedrene epoxide β-CE 18. Tetradecanal TTD 19. α-Humulene α-HM 20. β-Copaen-4-α-ol β-CP-4-α-ol 21. β-Selinene β-SL 22. α-Terpineol α-TP 23. γ-Terpinene γ-TP 24. β-Himachalene oxide β-HO 25. Undecanal UD 26. α-Calacorene α-CC 27. Methyl chavicol MC 28. Patchoulane PC 29. Terpine-4-ol TP-4-ol 30. trans-Caryophyllene tr-CP 31. α-Cadinol α-CD 32. 1-Octen-3-ol 1-OCT-3-ol 33. (Z)-1,3-Hexadiene (Z)-1,3,-HD 34. (Z)-3-Hexenol (Z)-3-HX 35. α-Muurolene α-MR 36. (E,E)-α-Farnesene (E,E)-α-FS 37. Camphor CP 38. δ-3-Carene δ-3-CR 39. Linalool J o u r n a l P r e -p r o o f This is the first and foremost holistic study to unravel COVID-19 immune responsive 620 targets and identify the novel bioactive compounds through multi-omics and 621 systems pharmacology analyses for combating COVID-19. 622 623 2. Immuno-transcriptomic study identified 98 immune responsive genes were 624 differentially expressed in COVID-19 cases. 625 626 3. Cheminformatics and interactome analysis unravels 154 active compounds and 627 targeting 13 COVID-19 associated immune genes A 25 potential compounds were found to be more efficacious than the WHO 631 prescribed drugs for the treatment of COVID-19 pandemic